Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;102(6):897-902.
doi: 10.1002/cpt.755. Epub 2017 Aug 10.

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

Affiliations

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

M V Relling et al. Clin Pharmacol Ther. 2017 Dec.

Abstract

The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The mission of Pharmacogenomics Research Network (PGRN) is to catalyze and lead research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects. (a) The main features in pgrn.org includes where members can find important information related to pharmacogenomics research opportunities. (b) About our current PGRN Members. To date, the new PGRN includes 271 members (top left panel). The breakdown of the membership shows that 93% of members are faculty at universities or staff in other sectors, and 7% are trainees (top right panel). Though most members are from the United States, 20% are from countries outside of the United States (bottom left panel). Currently, there are 14 main disease areas that are focused by the PGRN members (bottom right panel).
Figure 1
Figure 1
The mission of Pharmacogenomics Research Network (PGRN) is to catalyze and lead research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects. (a) The main features in pgrn.org includes where members can find important information related to pharmacogenomics research opportunities. (b) About our current PGRN Members. To date, the new PGRN includes 271 members (top left panel). The breakdown of the membership shows that 93% of members are faculty at universities or staff in other sectors, and 7% are trainees (top right panel). Though most members are from the United States, 20% are from countries outside of the United States (bottom left panel). Currently, there are 14 main disease areas that are focused by the PGRN members (bottom right panel).

References

    1. Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120:1165–1174. - PMC - PubMed
    1. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89:464–467. - PMC - PubMed
    1. Caudle KE, et al. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) Genet Med. 2016;19:215– 223. - PMC - PubMed
    1. Whirl-Carrillo M, et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012;92:414–417. - PMC - PubMed
    1. Yee SW, et al. Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration. Clin Pharmacol Ther. 2016;100:423–426. - PMC - PubMed

MeSH terms